L&K Biomed Co (XKRX:156100) ROCE % : -0.31% (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is L&K Biomed Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. L&K Biomed Co's annualized ROCE % for the quarter that ended in Sep. 2024 was -0.31%.

L&K Biomed Co ROCE % Historical Data

The historical data trend for L&K Biomed Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

L&K Biomed Co ROCE % Chart

L&K Biomed Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-27.73

-21.30

-17.48

-45.94

-16.34

L&K Biomed Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															23.49	-93.13	30.67	18.08	-0.31

L&K Biomed Co ROCE % Calculation

L&K Biomed Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4466.332	/	( ( (52663.334 - 37980.728)	+	(62762.238 - 22763.225) )	/ 2 )
	=	-4466.332	/	( (14682.606	+	39999.013)	/ 2 )
	=	-4466.332	/	27340.8095
	=	-16.34 %

L&K Biomed Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-130.316	/	( ( (78410.436 - 36352.725)	+	(78214.97 - 37361.61) )	/ 2 )
	=	-130.316	/	( ( 42057.711	+	40853.36 )	/ 2 )
	=	-130.316	/	41455.5355
	=	-0.31 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

L&K Biomed Co (XKRX:156100) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

L&K Biomed Co ROCE % Related Terms

Thank you for viewing the detailed overview of L&K Biomed Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

L&K Biomed Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » L&K Biomed Co Ltd (XKRX:156100) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Floor, 159-1, Mokdongseo-ro, Yangcheon-gu, Seoul, KOR

Website

http://www.lnkbiomed.com

L&K Biomed Co Ltd is a medical device manufacturer. The company develops, manufactures and markets orthopedic spinal implant of medical devices. Its products are Anterior Cervical plate, Posterior cervical fixation, and Anteiro cervical cage system.

L&K Biomed Co Headlines

No Headlines